ククレブ・アドバイザーズ提供のB2Bポータルサイト
IR Storage
Disclosed
Company
Industry
Category
Title
Disclosed
26/10/28 16:00
Company
Nxera Pharma Co., Ltd.
Industry
Pharmaceutical
Category
Other
Title
Nxera Pharma Secures Exclusive Rights to Fabry Disease Phase 3 Oral Therapy Candidate Lucerastat for Japan and Selected Asia Pacific Markets
